Aprocitentan (TRYVIO)
Aprocitentan (TRYVIO), is the first and only endothelin receptor antagonist for the treatment of high blood pressure not adequately controlled in combination with 3 combined antihypertensive class drugs. Aprocitentan is a dual endothelin receptor antagonist that inhibits the binding of ET-1 to both...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Wolters Kluwer Medknow Publications
2024-04-01
|
| Schriftenreihe: | Amrita Journal of Medicine |
| Schlagworte: | |
| Online-Zugang: | https://journals.lww.com/amjm/fulltext/2024/20020/aprocitentan__tryvio_.8.aspx |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|